Clinical Section

There are two clinical units in Triumpharma building (Amman–Jordan).. They are designed to meet world-class specifications and all activities are conducted in strict compliance with Global Regulatory Standards. Triumpharma clinical site is a dedicated for clinical trials conduct (Bioequivalence, Bioavailability and clinicaltrials sPhase I, II, III and IV).

Our clients are relying on our site to consistently meet or exceed enrolment goals and capture accurate, high quality data while maintaining superior standards of care in accordance with Local, international regulations and ICH/GCP guidelines.


Triumpharma houses its clinical centers on the Second & Third floors of the present building to conduct clinical evaluations.

1 well-equipped, controlled access, on-site pharmacy

The clinical site possesses ample space to comfortably accommodate subjects during routine and extended visits and offer secure record storage on site PK Sample storage area (with 20°C and -80°C deep freezers).

Well-equipped Emergency rooms in each floor

Large database of more than 3000 healthy volunteers, and patients for numerous therapeutic categories.

Up to 80 beds connected to nurse calling system plus 2 Special care beds at emergency rooms.

Dosing, dormitories rooms and sample processing areas equipped to handle light sensitive drugs.

Catering for regular & special diets through our contract with specialized restaurants.  

Triumpharma has its medical ward accredited by the JFDA at private hospital located in Amman -Jordan for conduction of clinical trials with capacity of 14 beds plus 34 Special care beds for intensive monitoring at ICU/CCU. The partnership with the hospital management also enables faster site activation through efficient Clinical Trial Agreement negotiations with the investigators. 

In addition, we have developed a multi-site hospital partnership model to meet client needs and provide the best outcome for sponsors and patients alike with a capacity of more than 100 beds in several Hospital settings.